In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary...
Montreal Children's Hospital, 2300 Tupper St., Rm C-417, Montreal Children's Hospital, 2300 Tupper St., Rm C-417, CA/channelsCategory:聽Montreal Children's Hospital
Medicine and Health Sciences